BioXCell熱銷產(chǎn)品--RecombiMAb anti-mouse PD-1 (CD279)
?
產(chǎn)品描述：
29F.1A12?-CP004單克隆抗體是原始29F.1A12?克隆號(hào)的重組嵌合型抗體?？勺兘Y(jié)構(gòu)域序列與原始29F.1A12?克隆號(hào)相同，但是恒定區(qū)序列已經(jīng)從大鼠IgG2a變?yōu)樾∈驣gG1。29F.1A12?-CP004抗體像原始大鼠IgG2a抗體一樣無(wú)Fc突變。
29F.1A12?-CP004單克隆抗體與小鼠PD-1（程序性死亡-1蛋白，也稱為CD279）反應(yīng)。PD-1是一種50-55 kDa的細(xì)胞表面受體，由Pdcd1基因編碼，屬于免疫球蛋白超家族的CD28家族。PD-1在CD4和CD8胸腺細(xì)胞以及活化的T和B淋巴細(xì)胞和骨髓細(xì)胞上瞬時(shí)表達(dá)。成功清除抗原后，PD-1表達(dá)下降。此外，Pdcd1 mRNA在前B細(xì)胞階段發(fā)育中的B淋巴細(xì)胞中表達(dá)。PD-1的結(jié)構(gòu)包括一個(gè)ITIM(免疫受體酪氨酸抑制基序),表明PD-1負(fù)調(diào)節(jié)TCR信號(hào)。PD-1通過(guò)結(jié)合它的兩個(gè)配體PD-L1和PD-L2發(fā)出信號(hào)，這兩個(gè)配體都是B7家族的成員。配體結(jié)合后，PD-1信號(hào)抑制T細(xì)胞活化，導(dǎo)致增殖、細(xì)胞因子產(chǎn)生和T細(xì)胞死亡減少。此外，已知PD-1在小鼠的外周耐受性和預(yù)防自身免疫性疾病中起關(guān)鍵作用，因?yàn)镻D-1敲除動(dòng)物表現(xiàn)出擴(kuò)張性心肌病、脾腫大和外周耐受性喪失。誘導(dǎo)的PD-L1表達(dá)常見于許多腫瘤，包括鱗狀細(xì)胞癌、結(jié)腸腺癌和乳腺腺癌。PD-L1過(guò)度表達(dá)導(dǎo)致腫瘤細(xì)胞對(duì)CD8 T細(xì)胞介導(dǎo)的裂解的抗性增加。在黑色素瘤的小鼠模型中，通過(guò)用阻斷PD-L1和它的受體PD-1之間的相互作用，腫瘤生長(zhǎng)可以暫時(shí)被抑制。目前PD-1是癌癥免疫療法的熱門靶點(diǎn)之一。
?
產(chǎn)品詳情：
產(chǎn)品名稱 | RecombiMAb anti-mouse PD-1 (CD279) |
產(chǎn)品貨號(hào) | CP004 |
產(chǎn)品規(guī)格 | 1mg |
反應(yīng)種屬 | Mouse |
克隆號(hào) | 29F.1A12?-CP004 |
同種型 | Mouse IgG1(switched from rat IgG2a) |
免疫原 | Recombinant PD-1-Ig fusion protein |
實(shí)驗(yàn)應(yīng)用 | in vivo blocking of PD-1/PD-L signaling* in vitro PD-1 neutralization* Immunohistochemistry (frozen)* Immunofluorescence* Western blot* Flow cytometry* *Reported for the original rat IgG2a 29F.1A12 antibody |
產(chǎn)品形式 | PBS, pH 7.0,Contains no stabilizers or preservatives |
純度 | >95%, Determined by SDS-PAGE |
聚合 | <5%, Determined by SEC |
無(wú)菌處理 | 0.2 μm filtration |
純化方式 | Protein G |
分子量 | 150 kDa |
小鼠病原檢測(cè) | Ectromelia/Mousepox Virus: Negative Hantavirus: Negative K Virus: Negative Lactate Dehydrogenase-Elevating Virus: Negative Lymphocytic Choriomeningitis virus: Negative Mouse Adenovirus: Negative Mouse Cytomegalovirus: Negative Mouse Hepatitis Virus: Negative Mouse Minute Virus: Negative Mouse Norovirus: Negative Mouse Parvovirus: Negative Mouse Rotavirus: Negative Mycoplasma Pulmonis: Negative Pneumonia Virus of Mice: Negative Polyoma Virus: Negative Reovirus Screen: Negative Sendai Virus: Negative Theiler’s Murine Encephalomyelitis: Negative |
保存條件 | 抗體原液保存在4°C，不能冷凍保存。 |
推薦同型對(duì)照 | InVivoPlus mouse IgG1 isotype control, unknown specificity（貨號(hào)BP0083） |
推薦抗體稀釋液 | InVivoPure pH 7.0 Dilution Buffer（貨號(hào)IP0070） |
?
該產(chǎn)品自上市已被多篇SCI文獻(xiàn)引用，品質(zhì)有保證，以下是部分已發(fā)表的文獻(xiàn)引用：
| 應(yīng)用 | 文章 |
體內(nèi)PD-1/PD-L信號(hào)阻斷 (in vivo blocking of PD-1/ PD-L signaling) | 1.?Wang, W., et al. (2018). 'RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune? Tolerance in Pancreatic Cancer' Cancer Cell 34(5): 757-774 e757.
2.?Gordon, S. R., et al. (2017). 'PD-1 expression by tumour-associated macrophages? inhibits phagocytosis and tumour immunity' Nature 545(7655): 495-499.
3.?Koyama, S., et al. (2016). 'STK11/LKB1 Deficiency Promotes Neutrophil Recruitment? and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor? Microenvironment' Cancer Res 76(5): 999-1008. |
體內(nèi)PD-1/PD-L信號(hào)阻斷， 流式細(xì)胞術(shù) (in vivo blocking of PD-1/ PD-L signaling,?Flow Cytometry) | 1.Koyama, S., et al. (2016). 'Adaptive resistance to therapeutic PD-1 blockade is? associated with upregulation of alternative immune checkpoints' Nat Commun 7: 10501. |
體外PD-1中和 （in vitro PD-1 neutralization） | 1.Park, S. J., et al. (2014). 'Negative role of inducible PD-1 on survival of activated? dendritic cells' J Leukoc Biol 95(4): 621-629. |
體內(nèi)PD-1/PD-L信號(hào)阻斷， 體外PD-1中和（in vivo blocking? of PD-1/PD-L signaling,?in vitro? PD-1?neutralization） | 1.Duraiswamy, J., et al. (2013). 'Dual blockade of PD-1 and CTLA-4 combined with? tumor vaccine effectively restores T-cell rejection function in tumors' Cancer Res 73 (12): 3591-3603. |
流式細(xì)胞術(shù) （Flow Cytometry） | 1.Good-Jacobson, K. L., et al. (2012). 'CD80 expression on B cells regulates murine? T follicular helper development, germinal center B cell survival, and plasma cell? generation'?J Immunol 188(9): 4217-4225. |
?
更多產(chǎn)品詳情請(qǐng)咨詢?BioXCell?中國(guó)授權(quán)代理——欣博盛生物
全國(guó)服務(wù)熱線: 4006-800-892 ? ? ??郵箱: market@neobioscience.com?
深圳: 0755-26755892 ? ? ? ??北京: 010-88594029 ???????????
廣州：020-87615159???????????上海: 021-34613729
代理品牌網(wǎng)站: m.smblzp.com?
自主品牌網(wǎng)站: www.neobioscience.net?